Identifies potential merger targets in the technology, healthcare, and logistics industries. Conducts due diligence on potential target companies. Now — the numbers.
There is not enough trading history here to call this an established business.
If every debt were paid off today, $944K would still be left — though next to the size of the company that is a thin cushion.
The market pays 1,045× for every dollar this company earns in a year — a price that already assumes things go well.
No analyst target is on record for this company.
Executives buying with their own money is usually read as confidence in the company’s future.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
There is $944K in the vault; even if every debt were paid off, $944K would remain.
Over the last 12 months, company executives reported 6 buys and 1 sell. Management buying with its own money is usually read as a good sign.
Our checks did not surface a specific risk to flag here. That is not the same as there being none.
We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the growth trend, earnings execution, the revenue breakdown.